Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. COLLABORATION AND LICENSE AGREEMENT By and Among Momenta Pharmaceuticals, Inc. and Biochemie West Indies, N.V. and...Collaboration and License Agreement • November 8th, 2012 • Momenta Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York
This Collaboration and License Agreement (“Agreement”) is entered into as of this 1st day of November, 2003 (“Effective Date”), by and between Momenta Pharmaceuticals, Inc., a Delaware corporation (“Momenta”) with a principal place of business at 43 Moulton Street, Cambridge, Massachusetts, USA 02138, Biochemie West Indies, N.V., a Netherlands Antilles corporation (“BCWI”) with a principal place of business at Pietermaai 6A, Willemstad, Curacao, Netherlands Antilles, and Geneva Pharmaceuticals, Inc., a Colorado corporation (“Sandoz”) with a principal place of business at 506 Carnegie Center, Suite 400, Princeton, New Jersey USA 08540 (Sandoz, collectively with BCWI, are the “Sandoz Parties”, and individually, each is a “Sandoz Party”).
